Cholic Acid
| 製品名 | Cholic Acid |
|---|---|
| CAS番号 | 81-25-4 |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 分子式 | C24H40O5 |
| 分子量 | 408.57 g/mol |
| 融点 | 197–201 °C |
| 比回転 | [α]D20 +37° (c=1, ethanol) |
| 溶解度 | Soluble in ethanol, acetone; slightly soluble in water |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| パッケージ | 25 kg fiber drum with inner polyethylene bag |
お困りですか? 弊社チームまでお問い合わせください

同義語: 3α,7α,12α-Trihydroxy-5β-cholan-24-oic acid; Cholan-24-oic acid, 3,7,12-trihydroxy-, (3α,5β,7α,12α)-; Cholic acid; Cholalic acid; 17β-(1-Methyl-3-carboxypropyl)etiocholane-3α,7α,12α-triol
Cholic acid is a primary bile acid biosynthesized in the liver from cholesterol via the classical pathway involving CYP7A1, CYP8B1, and CYP27A1. It is the most abundant bile acid in human bile, typically conjugated with glycine or taurine to form glycocholic and taurocholic acids, which are essential for emulsifying dietary fats and facilitating their absorption in the small intestine. As a pharmaceutical-grade raw material, it serves as a critical starting material for the synthesis of ursodeoxycholic acid (UDCA) and other bile acid derivatives.
Beyond its role in bile acid metabolism, cholic acid has gained significant attention in drug delivery and formulation science. Its amphiphilic nature enables the formation of mixed micelles and liposomes, enhancing the solubility and permeability of poorly water-soluble drugs. In the pharmaceutical industry, it is also used as a choleretic agent and in the treatment of bile acid synthesis disorders. Our cholic acid is manufactured under cGMP conditions, ensuring consistent quality and regulatory compliance for demanding applications.
| パラメータ | 仕様 |
|---|---|
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | ≥98.0% |
| 融点 | 197–201 °C |
| 比回転 | +36° to +38° (c=1, ethanol) |
| 乾燥減量 | ≤0.5% |
| 重金属 | 10 ppm以下 |
| 焼失残渣 | ≤0.11 TP3T |